blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1191924

EP1191924 - PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF (D-THREO)-METHYLPHENIDATE AND A SECOND CNS STIMULANT [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  03.02.2006
Database last updated on 19.10.2024
Most recent event   Tooltip03.02.2006Withdrawal of applicationpublished on 22.03.2006  [2006/12]
Applicant(s)For all designated states
Pharmaquest Limited
Reid House, 31 Church Street
Hamilton HM 12 / BM
For all designated states
THE McLEAN HOSPITAL CORPORATION
115 Mill Street
Belmont, MA 02178 / US
[2002/14]
Inventor(s)01 / MIDHA, Kamal K.
195 South Shore Road, Paget
Hamilton / BM
02 / TEICHER, Martin
40 Livingstone Lane
Waltham, MA 02453 / US
 [2002/14]
Representative(s)Mallalieu, Catherine Louise, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2002/14]Mallalieu, Catherine Louise, et al
D. Young & Co., 21 New Fetter Lane
London EC4A 1DA / GB
Application number, filing date00921958.506.04.2000
[2002/14]
WO2000US09472
Priority number, dateUS19990127984P06.04.1999         Original published format: US 127984 P
[2002/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0059481
Date:12.10.2000
Language:EN
[2000/41]
Type: A1 Application with search report 
No.:EP1191924
Date:03.04.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 12.10.2000 takes the place of the publication of the European patent application.
[2002/14]
Search report(s)International search report - published on:US12.10.2000
(Supplementary) European search report - dispatched on:EP28.12.2004
ClassificationIPC:A61K9/20, A61K9/58, A61P25/24
[2005/06]
CPC:
A61K31/485 (EP,US); A61K31/435 (EP,US); A61K31/44 (EP,US);
A61K31/4458 (EP,US); A61K45/06 (EP,US); A61K9/4808 (EP,US);
A61K9/5084 (EP,US); A61P25/00 (EP); A61P25/08 (EP);
A61P25/14 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/26 (EP); A61P25/28 (EP); A61P31/18 (EP);
A61K9/1676 (EP,US); A61K9/2009 (EP,US); A61K9/2054 (EP,US);
A61K9/2059 (EP,US); A61K9/2081 (EP,US); A61K9/2853 (EP,US);
A61K9/5078 (EP,US) (-)
C-Set:
A61K31/4458, A61K2300/00 (EP,US);
A61K31/485, A61K2300/00 (US,EP)
Former IPC [2002/14]A61K9/20, A61K9/58
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/14]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:PHARMAZEUTISCHE DARREICHUNGSFORM ZUR GEPULSTEN VERABREICHUNG VON (D-THREO)-METHYLPHENIDAT UND EINEM WEITEREN ZNS STIMULIERENDEN STOFF[2002/14]
English:PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF (D-THREO)-METHYLPHENIDATE AND A SECOND CNS STIMULANT[2002/14]
French:FORME POSOLOGIQUE PHARMACEUTIQUE DESTINEE A L'ADMINISTRATION INTERMITTENTE DE (D-THREO)-METHYLPHENIDATE ET D'UN SECOND STIMULANT DU SYSTEME NERVEUX CENTRAL[2002/14]
Entry into regional phase15.10.2001National basic fee paid 
15.10.2001Search fee paid 
15.10.2001Designation fee(s) paid 
15.10.2001Examination fee paid 
Examination procedure26.10.2000Request for preliminary examination filed
International Preliminary Examining Authority: US
11.10.2001Amendment by applicant (claims and/or description)
15.10.2001Examination requested  [2002/14]
30.01.2006Application withdrawn by applicant  [2006/12]
Fees paidRenewal fee
12.04.2002Renewal fee patent year 03
14.04.2003Renewal fee patent year 04
15.04.2004Renewal fee patent year 05
13.04.2005Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[Y]US4957494  (WONG PATRICK S L [US], et al);
 [X]US5837284  (MEHTA ATUL M [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.